Treatment of refractory bullous pemphigoid with IFN‐α‐2b: A case report | Zendy

Wang Tianjing | Zendy; Xu Yingping | Zendy; Ren Yingying | Zendy; Luo Guangpu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Treatment of refractory bullous pemphigoid with IFN‐α‐2b: A case report

Author(s) -

Wang Tianjing,

Xu Yingping,

Ren Yingying,

Luo Guangpu

Publication year - 2019

Publication title -

dermatologic therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.595

H-Index - 68

eISSN - 1529-8019

pISSN - 1396-0296

DOI - 10.1111/dth.13080

Subject(s) - medicine , bullous pemphigoid , refractory (planetary science) , dermatology , erythema multiforme , erythema , blisters , pemphigoid , immunoglobulin e , immunology , antibody , physics , astrobiology

We reported a patient with refractory bullous pemphigoid (BP), who had a higher level of eosinophils and serum IgE. The case showed less response to various therapies. Edematous erythema and new blisters appeared constantly. Considering IFN‐α‐2b treatment could significantly decrease blood eosinophils, we therefore expected that IFN‐α‐2b could be effective in the treatment of BP. After treated with IFN‐α‐2b, the patient's good response to the treatment suggested our hypothesis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research